Rm. Huber et al., DOES ADDITIONAL BRACHYTHERAPY IMPROVE THE EFFECT OF EXTERNAL IRRADIATION - A PROSPECTIVE, RANDOMIZED STUDY IN CENTRAL LUNG-TUMORS, International journal of radiation oncology, biology, physics, 38(3), 1997, pp. 533-540
Citations number
34
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Endobronchial brachytherapy has become more widely used to in
crease the total local dose of irradiation (''boost'') applied for the
treatment of lung cancer, Apart from treatment for local stenosis, en
dobronchial brachytherapy in combination with external irradiation (EI
) has the potential to improve local tumor control and perhaps prolong
survival, but the real benefit has not been proven yet, To evaluate t
he possible effects of external irradiation with an additional boost o
f high dose rate (HDR) brachytherapy, we conducted a prospective rando
mized study. Methods and Materials: Design-two groups were compared: G
roup 1 was treated with external radiotherapy alone (planned dose 60 G
y); Group 2 received an additional boost of HDR brachytherapy of sched
uled 4.8 Gy each (at 10 mm from the source axis) before and after exte
rnal irradiation, Patients-98 patients with advanced inoperable lung c
ancer were included in the study, 42 in Group 1 and 56 in Group 2, Bot
h groups were comparable with respect to age, sex, tumor stage, Karnof
sky performance status (KPS), and histology. Results: A mean total ext
ernal irradiation dose of 50.5 +/- 14.1 Gy in Group 1 and 50 +/- 12.5
Gy in Group 2 was applied, Group 2 received an additional dose of 7.44
+/- 2.6 Gy (at 10 mm depth) through brachytherapy. The median surviva
l time in both groups was comparable (28 weeks and 27 weeks, respectiv
ely), In patients with squamous cell carcinoma (68 patients) Group 2 s
howed an advantage in median survival with borderline significance (40
vs, 33 weeks, p = 0.09), Group 2 showed also a better local tumor con
trol in all patients; patients with squamous cell carcinoma had a sign
ificantly longer period of local tumor control, Fatal hemoptysis was t
he cause of death in 6 (14.2%) patients in Group 1 and 11 (18.9%) in G
roup 2 (p = 0.53). Conclusions: High dose rate brachytherapy in patien
ts with inoperable lung cancer increased local control in our randomiz
ed study when used in combination with external irradiation, Survival
time was also longer, but with no clear statistical significance, This
applied especially to patients with squamous cell carcinomas, There w
as no statistically significant difference in the incidence of fatal h
emoptysis between the two groups. (C) 1997 Elsevier Science Inc.